Gordon Empey
Gordon Empey is Chief Operating Officer, General Counsel and Partner at Frazier Life Sciences. He previously served as Partner at Cooley and as Vice President and General Counsel at Radiant Research. His specialties include venture capital financings, mergers and acquisitions, corporate governance, and licensing and strategic agreements.
Frazier Life Sciences Appoints Gordon Empey as Chief Operating Officer
Frazier Life Sciences named Gordon Empey as its new Chief Operating Officer, reinforcing leadership at the investment firm that focuses on innovative therapeutics.
Frazier Healthcare Partners launches $100M SPAC, Frazier Lifescience Acquisition Corporation (FLAC), to pursue biotech deals
Seattle venture firm Frazier Healthcare Partners filed with the SEC to raise $100 million for a SPAC called Frazier Lifescience Acquisition Corporation (FLAC) led by four Frazier executives, aiming to target biotechnology companies to develop therapies and generate investor returns.
Frazier Healthcare Partners closes $617M Frazier Life Sciences X fund to back therapeutics-focused biopharma startups
Frazier Healthcare Partners closed a $617 million life sciences fund, Frazier Life Sciences X, to invest in therapeutics-focused biopharma companies across all stages with an emphasis on seed and Series A rounds. The firm, founded in 1991 with $4.8 billion raised to date, also announced multiple Life Sciences team promotions.
Organizations
See all 6-
Frazier Life Sciences Partner, COO and General Counsel 2017–present · current
-
Empey PLLC Member 2017–2019 · past
-
Cooley Partner 2008–2017 · past
Education
-
University of California, Berkeley - School of Law JD, Law · 1991–1994
-
Colgate University B.A., History · 1986–1990
-
Navy OIS